Digital group (n = 94) | Traditional group (n = 115) | ASMD | |
---|---|---|---|
Age, years, mean (SD) | 67 (9) | 66 (11) | 0.10 |
Male, n (%) | 57 (60.6) | 61 (53.0) | 0.15 |
Co-morbidity, n (%) | 68 (72.3) | 89 (77.4) | 0.05 |
COPD, n (%) | 15 (16.0) | 12 (10.4) | 0.17 |
Asthma, n (%) | 3 (3.2) | 3 (2.6) | 0.04 |
FEV1, %, mean (SD) | 96.6 (20.2) | 98.9 (20.4) | 0.11 |
FVC, %, mean (SD) | 101.6 (19.9) | 103.9 (18.9) | 0.12 |
Tiffeneau, %, mean (SD) | 77.7 (9.7) | 76.8 (12.0) | 0.08 |
DLCO, %, mean (SD) | 83.1 (18.4) | 81.6 (19.0) | 0.08 |
Induction CT, n(%) | 6 (6.4) | 3 (2.6) | 0.18 |
Induction RT, n(%) | 0 (0.0) | 0 (0.0) | 0.0 |
Surgical time, min, mean (SD) | 164 (67) | 169 (65) | 0.08 |
Hemostatic devices, n (%) | 49 (52.1) | 52 (45.2) | 0.14 |
Type of lobectomy, n (%) | |||
Right upper lobectomy | 24 (25.5) | 35 (30.4) | 0.11 |
Right middle lobectomy | 6 (6.4) | 8 (6.9) | 0.00 |
Right lower lobectomy | 15 (15.9) | 15 (13.0) | 0.08 |
Left upper lobectomy | 32 (34.0) | 28 (24.3) | 0.20 |
Left lower lobectomy | 17 (18.1) | 29 (25.2) | 0.15 |
Lymphadenectomy, n (%) | 93 (98.9) | 113 (98.3) | 0.05 |
Systematic | 72 (76.6) | 86 (74.8) | 0.04 |
Sampling | 21 (22.3) | 27 (23.5) | 0.03 |